Neuroblastoma is a cancerous tumor that begins in nerve tissue of very young children, usually beginning in the abdomen or adrenal glands. Abnormal nerve cells may be present before birth, but the diagnosis isn’t made until the cells begin to multiply, forming a tumor. Neuroblastoma is most commonly diagnosed in children less than 5 years of age and is very rare after the age of 10.
How Dana-Farber/Boston Children’s approaches neuroblastoma
Because neuroblastoma is rarely seen in adults, it is important that your child receive care from an experienced team of pediatric specialists who focus exclusively on treating childhood cancers. The Neuroblastoma Program at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center treats newly diagnosed and relapsed patients and provides innovative therapies for children with relapsed or hard-to-treat neuroblastomas.
Our Neuroblastoma Program is one of the few pediatric cancer programs in the United States—and the only program in New England—offering MIBG therapy, a targeted form of radiation therapy for refractory neuroblastoma.
Our neuroblastoma specialists and surgeons are known for treating children with the most complex cases, as well as for their expertise in delivering specialized treatments, including stem cell transplants. Our Stem Cell Transplant Center is one of the largest and most experienced in the world.
Find more in-depth information about neuroblastoma on the Dana-Farber/Boston Children’s website, including answers to:
- What causes neuroblastoma?
- What are the symptoms of neuroblastoma?
- How is neuroblastoma diagnosed?
- How is neuroblastoma treated?
- What is the lastest research on neuroblastoma?
- What is the long-term outlook for children with neuroblastoma?